Prediction of Disease Severity by Beta 2 Microglobulin Levels In Hodgkin Lymphoma
Journal Title: Scholars Academic Journal of Biosciences - Year 2016, Vol 4, Issue 3
Abstract
Hodgkin's lymphoma (HL) also known as Hodgkin lymphoma or Hodgkin's disease is a type of lymphoma, in which cancer originates from a specific type of white blood cells, called B lymphocytes. When lymph nodes of Hodgkin’s lymphoma are examined microscopically, multinucleated Reed–Sternberg cells (RS cells) are the characteristic histopathological finding. In this study we studied the role of beta 2 microglobulin (B2M) as a marker of disease severity in Hodgkin lymphoma. 30 patients, diagnosed with Hodgkin lymphoma and 30 age and sex matched healthy controls were included in this study. All patients were given 6 cycles of ABVD regimen. Sample was analysed for routine biochemistry and B2M. B2M levels were estimated by a commercial Enzyme Linked Immunosorbent Assay kit for human B2M (DRG β2-MG ELISA). Mean serum B2M was 0.40± 0.38 µg/ml in controls. Levels were significantly raised in HL patients (4.20±1.88µg/ml, p<0.01).In this study 13(43.34%) patients presented with late stage (III + IV) and 17(56.66%) patients presented with early stage (I + II). It was found that patients with late stage had comparatively higher mean B2M levels (7.02±0.023µg/ml) as compared to those earlier stages(3.2±0.065µg/ml).This correlation was found to be statistically significant (p<0.01). Male patients suffering from HL had higher B2M (4.83±1.24 µg/ml) levels as compared to females (3.89±1.32 µg/ml) but the difference was statistically not significant. Patients with mediastinal large lymphnodes (bulky lymphadenopathy) had higher B2M levels (5.11±0.22 µg/ml) as compared to other HL patients (3.65±0.16, p <0.05 µg/ml).HL patients who presented with B symptoms had higher B2M levels (4.81±0.20 µg/ml) as compared to those without B symptoms (4.11±0.65, p>0.05 µg/ml). The conclusion in our study, B2M was found to be significantly associated with the severity of disease. Though, B2M has been discovered long time back but its role as a marker for the severity of disease has not been studied extensively, so still larger studies with longer follow up are required to validate its role in Hodgkin lymphoma as a disease severity marker. Keywords: Hodgkin lymphoma, beta2 microglobulin, stages, lymphnodes.
Authors and Affiliations
Garima Gupta, V. Lokanathan, V S Ghalaut, Madhumita Sarkar, Tarun Sharma, Sumit Dokwal
In vitro studies on antioxidant activity of black tea or Camellia sinensis
This study examined the free radical scavenging potential of crude water, ethanol and isopropanol extracts of leaves of Camellia sinensis (Fam: Theaceae) or black tea leaves in vitro. Pharmacological history of this pla...
Cystic granulosa cell tumor of the ovary- diagnosed on histopathology: case report
Abstract: Granulosa cell tumor (GCT) is an uncommon malignant neoplasm primarily arises from the sex-cord stromal cells of the ovary. They represent about 5 to 8 % of all cancers of the ovary. They belong to the category...
COPD Exacerbations and Respiratory Viral Infections: A Perspective
Respiratory viruses are a major cause of concern for human population worldwide. Respiratory viral infections make it worse for patients suffering with lung diseases, such as, chronic obstructive pulmonary disease (COPD)...
Comparative Study on the Antifungal Property of Banana and Papaya Peel Extract on Candida albicans when added to Glucose Yeast Peptone Agar
Abstract: This study aims to compare the antifungal property of banana (Musa paradisiaca) and papaya (Carica papaya) peel extract to Candida albicans when added to Glucose Yeast Peptone Agar.In the study, Candida albican...
Clinical Profile & Management of Patients of Carcinoma Anorectum: A Retrospective and Prospective Study
Abstract: In the present study, we have done a retrospective as well as prospective study for the clinical profile of patients with carcinoma anorectum undergoing abdominoperineal resection, with special emphasis on clin...